Aptinyx Competitors

Delisted . USA . 
Stock . Aptinyx
APTXDelisted Stock  USD 0.07  0.01  16.67%   
Aptinyx competes with Aileron Therapeutics, ABVC Biopharma, CytomX Therapeutics, Assembly Biosciences, and Instil Bio; as well as few others. The company conducts business under Biotechnology sector and is part of Health Care industry. Analyzing Aptinyx competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Aptinyx to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Aptinyx competition on your existing holdings.
  
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Aptinyx's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.070.070.07
Details
Intrinsic
Valuation
LowRealHigh
0.070.070.07
Details

Aptinyx Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Aptinyx and its competitors represents the degree of relationship between the price movements of corresponding delisted stocks. A correlation of about +1.0 implies that the price of Aptinyx and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Aptinyx does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
ALLR
+ 0.67
NUVB
ALLR
+ 0.6
CTMX
ALLR
+ 0.56
ABVC
CTMX
+ 0.54
NLTX
ALLR
+ 0.48
NLTX
MGTA
+ 0.46
EVLO
  
High negative correlations   
NUVB
- 0.7
ALRN
TIL
- 0.68
MGTA
ALLR
- 0.66
ALRN
CTMX
- 0.63
EVLO
NLTX
- 0.54
EVLO
CTMX
- 0.47
MGTA

Risk-Adjusted Indicators

There is a big difference between Aptinyx Stock performing well and Aptinyx Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Aptinyx's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
EVLO  14.30  4.03  0.24 (0.47) 11.93 
(19.79)
 46.25 
(26.62)
 131.59 
MGTA  2.62  0.09  0.00  0.68  3.40 
(3.33)
 5.88 
(4.29)
 16.99 
ALRN  4.20  0.22  0.03  0.92  4.69 
(5.03)
 8.06 
(7.99)
 41.47 
ABVC  3.73 (0.27) 0.00  0.51  0.00 
 0.00 
 7.25 
(9.09)
 35.84 
NLTX  2.25 (0.17) 0.00  1.69  0.00 
 0.00 
 4.05 
(3.53)
 27.84 
CTMX  2.68 (0.45) 0.00 (0.24) 0.00 
 0.00 
 5.36 
(5.22)
 20.61 
ASMB  2.91  0.05  0.00  0.25  4.40 
(2.86)
 8.49 
(5.34)
 24.80 
TIL  9.31  1.37  0.24  0.39  6.84 
(12.68)
 20.63 
(10.89)
 105.83 
NUVB  3.77 (0.35) 0.00  0.03  4.59 
(4.01)
 9.48 
(8.36)
 21.30 
ALLR  4.99 (2.02) 0.00 (1.99) 0.00 
 0.00 
 10.85 
(16.11)
 41.48 
All Fundamental Data

Aptinyx Competitive Analysis

The better you understand Aptinyx competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Aptinyx's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Aptinyx's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
APTX EVLO MGTA ALRN ABVC NLTX CTMX ASMB TIL NUVB
 16.67 
 0.07 
Aptinyx
 24.56 
 8.23 
Evelo
 3.80 
 0.82 
Magenta
 0.40 
 2.46 
Aileron
 5.45 
 0.52 
ABVC
 1.43 
 0.69 
Neoleukin
 7.87 
 0.96 
CytomX
 1.53 
 14.81 
Assembly
 0.08 
 26.17 
Instil
 3.21 
 2.89 
Nuvation
Market Volatility
(90 Days Market Risk)
Very steady
Very steady
Very steady
Slightly risky
Out of control
Very steady
Dangerous
Relatively risky
Unstable
Risky
Market Performance
(90 Days Performance)
Very Weak
Very Weak
Very Weak
Weak
Very Weak
Very Weak
Very Weak
Very Weak
OK
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Dangerous
Dangerous
Dangerous
About Average
Very High
Dangerous
Average
Low
Average
About Average
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Over Valued
Under Valued
Over Valued
Over Valued
Under Valued
Over Valued
Over Valued
Under Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Strong Buy
Hold
Not Available
Buy
Strong Buy
Buy
Strong Buy
Trade Advice
(90 Days Macroaxis Advice)
Not Rated
Not Rated
Not Rated
Strong Sell
Strong Sell
Not Rated
Strong Sell
Strong Sell
Hold
Strong Sell
Current Ratio
16.22
4.53
10.22
6.51
2.68
12.78
2.05
8.31
8.51
33.58
Net Asset
66.68 M
64.44 M
146.65 M
106.01 M
14.49 M
115.95 M
201.79 M
136.82 M
325.63 M
621.48 M
Profit Margin
N/A
N/A
N/A
N/A
N/A
N/A
0.11
-2.12
N/A
N/A
EBITDA
(62.57 M)
(108.41 M)
(78.98 M)
(15.61 M)
(8.13 M)
(56.48 M)
(4.31 M)
(64.2 M)
(146.12 M)
(99.6 M)
Current Valuation
(25.91 M)
23.69 M
(32.66 M)
36.03 M
8.84 M
(35.02 M)
(31.84 M)
624.6 K
135.77 M
434.73 M
Price To Book
0.33
3.51
0.54
1.06
0.8
0.44
5.04
3.62
0.97
1.93
Operating Margin
N/A
N/A
N/A
N/A
-8.34
N/A
0.12
-1.43
N/A
-66.16
Retained Earnings
(352.74 M)
(529.22 M)
(402.03 M)
(288.52 M)
(65.42 M)
(451.06 M)
(723.45 M)
(785.75 M)
(580.98 M)
(342.8 M)
Current Asset
59.11 M
49.29 M
33.34 M
3.43 M
N/A
289 K
189.75 M
68.37 M
N/A
N/A
Beta
1.33
1.74
2.12
2.34
0.82
1.1
1.06
0.59
1.74
1.36
Number Of Employees
12
66
67
15
16
7
120
65
49
203
Shares Outstanding
67.72 M
18.93 M
60.66 M
21.67 M
12.24 M
2.35 M
78.26 M
6.36 M
6.53 M
335.57 M
Cash Flow From Operations
(59.68 M)
(101.23 M)
(67.09 M)
(19.81 M)
(4.24 M)
(45.61 M)
(56.03 M)
22.74 M
(82.03 M)
(68 M)
Total Debt
22.11 M
51.14 M
29.96 M
48 K
2.28 M
12.07 M
13.97 M
2.34 M
86.05 M
4.01 M
Return On Equity
-1.38
-62.33
-0.65
-0.44
-3.2
-0.38
-54.75
-1.02
-0.49
-0.96
Z Score
-9.34
-16.24
-3.88
N/A
N/A
-5.73
N/A
N/A
N/A
N/A
Return On Asset
-0.51
-0.83
-0.29
-0.26
-0.45
-0.19
0.0233
-0.35
-0.12
-0.14
Number Of Shares Shorted
2.23 M
430.1 K
383.03 K
233.27 K
186.19 K
26.4 K
5.67 M
7.95 K
376 K
11.32 M
Book Value Per Share
0.27
-1.42
1.24
1.41
1.06
34.18
-0.3
7.5
34.72
1.5
Current Liabilities
4.69 M
4.32 M
3.39 M
459 K
N/A
1.02 M
15.74 M
3.4 M
N/A
N/A
Total Asset
66.68 M
64.44 M
146.65 M
106.01 M
14.49 M
115.95 M
201.79 M
136.82 M
325.63 M
621.48 M
Debt To Equity
0.39
1.55
0.25
0.003
0.34
0.11
0.67
0.041
0.12
0.006
Short Ratio
1.13
0.42
1.38
3.47
0.7
1.7
9.58
0.41
2.29
7.28
Target Price
0.5
10.0
1.0
13.0
2.02
1.5
5.29
35.5
100.33
6.5
Shares Owned By Institutions
42.96
83.13
62.63
28.47
3.01
45.58
65.31
18.79
80.7
56.3
Market Capitalization
4.57 M
7 M
45.14 M
53.3 M
6.72 M
8.2 M
75.15 M
94.14 M
170.78 M
972.68 M
Price To Earning
-5.61
-4.19
-1.63
-0.31
N/A
-4.6
-11.41
-10.58
18.31
N/A
Price To Earnings To Growth
N/A
N/A
N/A
N/A
N/A
-0.03
-1.8
N/A
N/A
N/A
Price To Sales
45.33
N/A
N/A
N/A
49.27
N/A
0.59
4.38
55329.79
449.9
Net Income
(64.85 M)
(114.53 M)
(76.46 M)
(15.73 M)
(10.52 M)
(57.56 M)
(569 K)
(61.23 M)
(156.09 M)
(75.8 M)
Earnings Per Share
-0.65
-15.64
-1.11
-2.88
-0.77
-12.28
0.16
-6.89
-11.56
-2.18
Shares Owned By Insiders
13.12
0.23
2.23
0.6
22.92
16.46
1.0
31.62
12.86
26.85
Revenue
N/A
N/A
N/A
N/A
152.43 K
N/A
101.21 M
7.16 M
N/A
N/A
Working Capital
57.74 M
39.18 M
101.05 M
13.88 M
(4.28 M)
88.07 M
27.02 M
94.56 M
150.2 M
602.46 M
Cash And Equivalents
85.27 M
92.01 M
128.28 M
32.38 M
2.99 M
116.46 M
194.29 M
116.69 M
354.61 M
703.8 M
Cash Per Share
1.26
0.85
2.13
0.36
0.09
2.73
2.94
2.41
2.73
3.22
Gross Profit
(54.44 M)
N/A
N/A
(17.01 M)
350.71 K
N/A
53.16 M
(63.9 M)
138 K
N/A
Day Typical Price
0.0633
9.09
0.81
2.53
0.53
0.69
0.95
15.03
26.83
2.9
Accumulation Distribution
0.29
0.26
0.0482
0.0892
0.0545
0.0563
0.11
0.0583
0.11
0.0503
Market Facilitation Index
0.02
2.85
0.04
0.24
0.03
0.04
0.11
0.91
3.19
0.15
Daily Balance Of Power
0.5
(0.94)
0.75
(0.04)
(1.00)
(0.25)
0.6364
(0.25)
0.0063
0.6
Period Momentum Indicator
0.01
(2.68)
0.03
(0.01)
(0.03)
(0.01)
0.07
(0.23)
0.02
0.09
Rate Of Daily Change
1.17
0.75
1.04
1.0
0.95
0.99
1.08
0.98
1.0
1.03
Day Median Price
0.06
9.52
0.81
2.57
0.54
0.69
0.95
15.15
27.16
2.91
Price Action Indicator
0.015
(2.63)
0.025
(0.12)
(0.03)
(0.01)
0.05
(0.45)
(0.97)
0.03
Coefficient Of Variation
(607.06)
675.8
2966.12
2329.29
(1,710)
(2,179)
(1,247)
3868.87
805.35
3999.68
Mean Deviation
7.26
14.3
2.62
4.2
3.73
2.25
2.68
2.91
9.31
3.77
Jensen Alpha
(2.10)
4.03
0.0945
0.2151
(0.27)
(0.17)
(0.45)
0.051
1.37
(0.35)
Total Risk Alpha
(4.02)
(0.17)
(0.46)
(0.68)
(1.24)
(0.75)
(0.85)
(0.55)
(0.51)
(0.65)
Sortino Ratio
N/A
0.2377
(0.001)
0.026
N/A
N/A
N/A
(0)
0.238
(0)
Downside Variance
N/A
170.5
17.78
24.27
N/A
N/A
N/A
20.1
60.79
22.53
Standard Deviation
12.54
21.84
3.69
5.98
5.76
3.7
3.59
4.17
15.98
4.89
Kurtosis
11.31
6.07
3.46
6.34
7.44
13.95
1.56
3.48
11.95
0.1446
Potential Upside
12.5
46.25
5.88
8.06
7.25
4.05
5.36
8.49
20.63
9.48
Treynor Ratio
(9.13)
(0.47)
0.6786
0.9244
0.5078
1.69
(0.24)
0.2481
0.3907
0.0286
Maximum Drawdown
75.72
131.59
16.99
41.47
35.84
27.84
20.61
24.8
105.83
21.3
Variance
157.18
477.0
13.63
35.76
33.16
13.69
12.85
17.39
255.34
23.87
Market Risk Adjusted Performance
(9.12)
(0.46)
0.6886
0.9344
0.5178
1.7
(0.23)
0.2581
0.4007
0.0386
Risk Adjusted Performance
(0.12)
0.1227
0.0337
0.0415
(0.04)
(0.03)
(0.05)
0.0279
0.1044
0.0275
Skewness
(2.42)
1.96
(0.42)
1.46
1.77
(2.77)
0.7306
(0.52)
3.06
0.2292
Semi Deviation
N/A
11.93
3.4
4.69
N/A
N/A
N/A
4.4
6.84
4.59
Information Ratio
(0.17)
0.1421
(0)
0.0214
(0.08)
(0.08)
(0.12)
(0)
0.1161
(0)
Value At Risk
(16.67)
(26.62)
(4.29)
(7.99)
(9.09)
(3.53)
(5.22)
(5.34)
(10.89)
(8.36)
Expected Short fall
N/A
(19.79)
(3.33)
(5.03)
N/A
N/A
N/A
(2.86)
(12.68)
(4.01)
Downside Deviation
N/A
13.06
4.22
4.93
N/A
N/A
N/A
4.48
7.8
4.75
Semi Variance
N/A
142.43
11.57
21.99
N/A
N/A
N/A
19.32
46.84
21.04

Aptinyx Competition Performance Charts

Five steps to successful analysis of Aptinyx Competition

Aptinyx's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Aptinyx in relation to its competition. Aptinyx's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Aptinyx in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Aptinyx's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Aptinyx, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Aptinyx position

In addition to having Aptinyx in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Information Technology ETFs Thematic Idea Now

Information Technology ETFs
Information Technology ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Information Technology ETFs theme has 50 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Information Technology ETFs Theme or any other thematic opportunities.
View All  Next Launch
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Consideration for investing in Aptinyx Stock

If you are still planning to invest in Aptinyx check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aptinyx's history and understand the potential risks before investing.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Bonds Directory
Find actively traded corporate debentures issued by US companies
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY